Life-science tool stocks thrive away from Obamacare glare

NEW YORK (Reuters) – Away from the political spotlight on Obamacare and high medicine prices, a section of the U.S. healthcare industry is quietly thriving on the stock market.

Previous post
Next post

Leave a Reply

Your email address will not be published. Required fields are marked *